However, Smad3 palmitoylation mediated by palmitoyltransferase ZDHHC19 promotes activation of the TGF-β signaling pathway, and its interaction with EP300 promotes expression of mesenchymal markers in the mesenchymal subtype of GBM. The gene discussed is EP300; the disease is glioblastoma.